Statistics for Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data
Total visits
| views | |
|---|---|
| Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data | 0 |
Total visits per month
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:92db89a1-357a-460e-9aaf-878ee059c2ea | 28 |
| java.util.UUID:4cc75114-d876-4fa5-b6b4-0452767aebfd | 24 |
| Viney2021Ligand-CCBYNC.pdf | 4 |
| java.util.UUID:8e9e3da3-d4f8-4035-8ba7-3d107d3ae7b5 | 2 |